Natus Medical Inc
NTUS
NTUS was delisted on the 20th of July, 2022.
172 hedge funds and large institutions have $847M invested in Natus Medical Inc in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 66 increasing their positions, 61 reducing their positions, and 14 closing their positions.
210% more call options, than puts
Call options by funds: $31K | Put options by funds: $10K
12% more capital invested
Capital invested by funds: $753M → $847M (+$93.6M)
8% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 61
0% more funds holding
Funds holding: 172 → 172 (0)
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$6.74M |
| 2 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$5.25M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$5.17M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$4.64M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$2.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.09M |
| 2 |
Impax Asset Management Group
London,
United Kingdom
|
-$4.88M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.78M |
| 4 |
Goldman Sachs
New York
|
-$2.54M |
| 5 |
Diamond Hill Capital Management
Columbus,
Ohio
|
-$1.57M |
NTUS Hedge Fund Activity: Q1 2022 in Review
172 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q1 2022, worth a combined $847M — up 12% from $753M a quarter earlier.
Fund positioning in NTUS was balanced in Q1 2022: 14 funds opened new positions, 14 closed out, 66 added to existing stakes and 61 trimmed.
The largest buyer was Allspring Global Investments, adding an estimated $6.74M. The largest seller was Wellington Management Group, exiting entirely with an estimated $7.09M sold.
- 172 institutional investors held Natus Medical Inc (NTUS) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $847M of Natus Medical Inc stock for Q1 2022, up 12% quarter-over-quarter.
- 14 funds opened new Natus Medical Inc positions in Q1 2022 and 14 closed out, a net change of 0 holders.
- The largest Natus Medical Inc buyer in Q1 2022 was Allspring Global Investments, an estimated $6.74M added.
- The largest Natus Medical Inc seller in Q1 2022 was Wellington Management Group, an estimated $7.09M sold.
Based on aggregated 13F filings for Q1 2022.